scholarly journals Existing levee system economic evaluation methodology

2021 ◽  
Author(s):  
Edouard Durand ◽  
Yann Deniaud ◽  
Sébastien Patouillard
Keyword(s):  
Economic Evaluation ◽  
Evaluation Methodology ◽  
Levee System

scholarly journals Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and Developments

2018 ◽  
Vol 15 (11) ◽  
pp. 2459 ◽  
Author(s):  
Laura Bojke ◽  
Laetitia Schmitt ◽  
James Lomas ◽  
Gerry Richardson ◽  
Helen Weatherly
Keyword(s):  
Economic Evaluation ◽  
Cost Effectiveness ◽  
Natural Environment ◽  
Complex Interventions ◽  
Environmental Policies ◽  
Evaluation Methodology ◽  
Environmental Interventions ◽  
Urban Green Spaces ◽  
Scarce Resources ◽  
Indoor And Outdoor

Evaluation of the costs and outcomes associated with environmental policies and interventions is often required to inform public policy and allocate scarce resources. Methods to conduct assessments of cost-effectiveness have been developed in the context of pharmaceuticals, but have more recently been applied in public health, diagnostics, and other more complex interventions. The suitability of existing economic evaluation methodology has been explored in many contexts, however, this is yet to be undertaken for interventions and policies pertaining to the natural environment, such as urban green spaces and strategies to reduce indoor and outdoor air pollution. To make significant inroads into the evaluation of interventions and policies relating to the natural environment requires an understanding of the challenges faced in this context. Many of these challenges may be practical (data-related), however, a number are also methodological, and thus have implications for the appropriate framework for economic evaluation. This paper considers some of the challenges faced when conducting cost-effectiveness analyses in this context and explores what solutions have been proposed thus far. The intention is to help pave the way for consideration of which existing framework is most appropriate for the evaluation of natural environment (NE) interventions, or if a distinct framework is required. Environmental policies and interventions relating to the built environment, for example, housing, are not explicitly included here.

Techno-economic evaluation methodology for hydrogen energy systems

2021 ◽  
pp. 237-260
Author(s):  
Venkatakrishnan Balasubramanian ◽  
Nawshad Haque ◽  
Suresh Bhargava ◽  
Srinivasan Madapusi ◽  
Rajarathinam Parthasarathy
Keyword(s):  
Economic Evaluation ◽  
Energy Systems ◽  
Evaluation Methodology ◽  
Hydrogen Energy

An economic evaluation methodology for smallholder maize research and extension: Zimbabwe

1995 ◽  
Vol 47 (4) ◽  
pp. 367-385 ◽  
Author(s):  
J.A. MacMillan ◽  
G. Mudimu ◽  
J.F. MacRobert ◽  
L. Rugube ◽  
E. Guveya ◽  
...  
Keyword(s):  
Economic Evaluation ◽  
Evaluation Methodology

An automated environmental and economic evaluation methodology for the optimization of a sour water stripping plant

2013 ◽  
Vol 44 ◽  
pp. 56-68 ◽  
Author(s):  
Carmen M. Torres ◽  
Mamdouh Gadalla ◽  
Josep M. Mateo-Sanz ◽  
Laureano Jiménez
Keyword(s):  
Economic Evaluation ◽  
Evaluation Methodology ◽  
Sour Water

scholarly journals Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review

2020 ◽  
Vol 11 ◽  
Author(s):  
Hui-Yao Huang ◽  
Cheng-Cheng Liu ◽  
Yue Yu ◽  
Le Wang ◽  
Da-Wei Wu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Economic Evaluation ◽  
Impact Analysis ◽  
Health Economic Evaluation ◽  
Developed Countries ◽  
Pharmacoeconomic Evaluation ◽  
Evaluation Methodology ◽  
Cochrane Library ◽  
Cost Ratio ◽  
Price Discount

Background and Purpose: The availability of oncology biosimilars is deemed as a fundamental strategy to achieve sustainable health care. However, there is scarce systematic evidence on economic effectiveness of cancer biosimilars. We aimed to synthesize evidence from pharmacoeconomic evaluation of oncology biosimilars globally, provide essential data and methodological reference for involved stakeholders.Materials and Methods: This systematic review was conducted in PubMed, embase, the Cochrane library, CRD, ISPOR and NICE utill December 31, 2019. Information on basic characteristics, evaluation methodology and results were extracted. Quality of included studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards Checklist.Results: For 17 studies identified (13 from Europe and four from United States), the overall quality was generally acceptable. A total of seven biological molecules involved with filgrastim, EPOETIN α, and trastuzumab leading the three. The mostly common evaluation perspective was payer, but the time horizon varied greatly. There were ten studies which adopted cost minimization analysis to evaluate efficiency while seven studies adopted budget impact analysis to address affordability, with cost ratio and cost saving being its corresponding primary endpoint. Although the comparability of included studies was limited and specific results were largely affected by uptake and price discount rates of the oncology biosimilar, the comprehensive results consistently favored its promotion.Conclusion: Globally, the economic evaluation of cancer biosimilars is in its initial phase. However, limited evidence from developed countries consistently supported both cost-effectiveness of efficiency and affordability of oncology biosimilars, while they were largely affected by uptake and price discount rate.

Sign in / Sign up

Export Citation Format

Share Document